{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:25:41Z","timestamp":1787761541796,"version":"build-2784847793"},"reference-count":79,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T00:00:00Z","timestamp":1702771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"CAPES","award":["n\u00ba 88887.877789\/2023-00"],"award-info":[{"award-number":["n\u00ba 88887.877789\/2023-00"]}]},{"name":"CAPES","award":["n\u00ba 88887.798411\/2022-00"],"award-info":[{"award-number":["n\u00ba 88887.798411\/2022-00"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>The physiopathology of liver diseases is complex and can be caused by various factors. Bifidobacterium is a bacterial genus commonly found in the human gut microbiome and has been shown to influence the development of different stages of liver diseases significantly. This study investigated the relationship between the Bifidobacterium genus and liver injury. In this work, we performed a systematic review in major databases using the key terms \u201cBifidobacterium\u201d, \u201cALD\u201d, \u201cNAFLD\u201d, \u201cNASH\u201d, \u201ccirrhosis\u201d, and \u201cHCC\u201d to achieve our purpose. In total, 31 articles were selected for analysis. In particular, we focused on studies that used next-generation sequencing (NGS) technologies. The studies focused on assessing Bifidobacterium levels in the diseases and interventional aimed at examining the therapeutic potential of Bifidobacterium in the mentioned conditions. Overall, the abundance of Bifidobacterium was reduced in hepatic pathologies. Low levels of Bifidobacterium were associated with harmful biochemical and physiological parameters, as well as an adverse clinical outcome. However, interventional studies using different drugs and treatments were able to increase the abundance of the genus and improve clinical outcomes. These results strongly support the hypothesis that changes in the abundance of Bifidobacterium significantly influence both the pathophysiology of hepatic diseases and the related clinical outcomes. In addition, our critical assessment of the NGS methods and related statistical analyses employed in each study highlights concerns with the methods used to define the differential abundance of Bifidobacterium, including potential biases and the omission of relevant information.<\/jats:p>","DOI":"10.3390\/microorganisms11122999","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T05:41:35Z","timestamp":1702878095000},"page":"2999","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Role of Bifidobacterium in Liver Diseases: A Systematic Review of Next-Generation Sequencing Studies"],"prefix":"10.3390","volume":"11","author":[{"given":"Gabriel Henrique","family":"Hizo","sequence":"first","affiliation":[{"name":"Graduate Program in Gastroenterology and Hepatology Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre 90035-003, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8992-9697","authenticated-orcid":false,"given":"Pabulo Henrique","family":"Rampelotto","sequence":"additional","affiliation":[{"name":"Bioinformatics and Biostatistics Core Facility, Instituto de Ci\u00eancias B\u00e1sicas da Sa\u00fade, Universidade Federal do Rio Grande do Sul, Porto Alegre 91501-907, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Pezzino, S., Sofia, M., Faletra, G., Mazzone, C., Litrico, G., La Greca, G., and Latteri, S. (2022). Gut\u2013liver Axis and Non-alcoholic Fatty Liver Disease: A Vicious Circle of Dysfunctions Orchestrated by the Gut Microbiome. Biology, 11.","DOI":"10.3390\/biology11111622"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.3748\/wjg.v27.i37.6161","article-title":"Significance of Gut Microbiota in Alcoholic and Non-Alcoholic Fatty Liver Diseases","volume":"27","author":"Sharma","year":"2021","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic Liver Disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.3390\/curroncol30020141","article-title":"Altered Gut Microbiota Composition and its Potential Association in Patients with Advanced Hepatocellular Carcinoma","volume":"30","author":"Huo","year":"2023","journal-title":"Curr. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.micres.2016.07.001","article-title":"Bifidobacteria\u2014Insight into Clinical Outcomes and Mechanisms of its Probiotic Action","volume":"192","author":"Sarkar","year":"2016","journal-title":"Microbiol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Wang, L., Jiao, T., Yu, Q., Wang, J., Wang, L., Wang, G., Zhang, H., Zhao, J., and Chen, W. (2022). Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10010084"},{"key":"ref_7","first-page":"e59980","article-title":"Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing","volume":"152","author":"Shahi","year":"2019","journal-title":"J. Vis. Exp."},{"key":"ref_8","first-page":"e51709","article-title":"Next-generation Sequencing of 16S Ribosomal RNA Gene Amplicons","volume":"90","author":"Sanschagrin","year":"2014","journal-title":"J. Vis. Exp."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbrc.2015.12.083","article-title":"Analysis of the Microbiome: Advantages of Whole Genome Shotgun Versus 16S Amplicon Sequencing","volume":"469","author":"Ranjan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Purushothaman, S., Meola, M., and Egli, A. (2022). Combination of Whole Genome Sequencing and Metagenomics for Microbiological Diagnostics. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179834"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3390\/biology1020383","article-title":"Next-generation Sequencing: Application in Liver Cancer\u2014Past, Present and Future?","volume":"1","author":"Marquardt","year":"2012","journal-title":"Biology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014A Web and Mobile App for Systematic Reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_14","unstructured":"Aromataris, E., and Munn, Z. (2020). JBI Manual for Evidence Synthesis, JBI."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/jmf.2018.4357","article-title":"Lactobacillus rhamnosus Granules Dose-Dependently Balance Intestinal Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver Injury","volume":"23","author":"Gu","year":"2020","journal-title":"J. Med. Food"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary Cholesterol Drives Fatty Liver-Associated Liver Cancer by Modulating Gut Microbiota and Metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/MEG.0000000000001494","article-title":"Characterisation of Blood Microbiota in Patients with Liver Cirrhosis","volume":"31","author":"Kajihara","year":"2019","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wei, X., Yan, X., Zou, D., Yang, Z., Wang, X., Liu, W., Wang, S., Li, X., Han, J., and Huang, L. (2013). Abnormal Fecal Microbiota Community and Functions in Patients with Hepatitis B Liver Cirrhosis as Revealed by a Metagenomic Approach. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-175"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Dubinkina, V.B., Tyakht, A.V., Odintsova, V.Y., Yarygin, K.S., Kovarsky, B.A., Pavlenko, A.V., Ischenko, D.S., Popenko, A.S., Alexeev, D.G., and Taraskina, A.Y. (2017). Links of Gut Microbiota Composition with Alcohol Dependence Syndrome and Alcoholic Liver Disease. Microbiome, 5.","DOI":"10.1186\/s40168-017-0359-2"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ju\u00e1rez-Fern\u00e1ndez, M., Porras, D., Petrov, P., Rom\u00e1n-Sag\u00fcillo, S., Garc\u00eda-Mediavilla, M.V., Soluyanova, P., Mart\u00ednez-Fl\u00f3rez, S., Gonz\u00e1lez-Gallego, J., Nistal, E., and Jover, R. (2021). The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation. Antioxidants, 10.","DOI":"10.3390\/antiox10122001"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1039\/D1FO00249J","article-title":"Modulation of the Fecal Microbiome and Metabolome by Resistant Dextrin Ameliorates Hepatic Steatosis and Mitochondrial Abnormalities in Mice","volume":"12","author":"Zhang","year":"2021","journal-title":"Food Funct."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3892\/etm.2021.9862","article-title":"Distinctive Gut Microbial Dysbiosis Between Chronic Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease in Mice","volume":"21","author":"Kang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Liu, J., Sun, J., Yu, J., Chen, H., Zhang, D., Zhang, T., Ma, Y., Zou, C., Zhang, Z., and Ma, L. (2023). Gut Microbiome Determines Therapeutic Effects of OCA on NAFLD by Modulating Bile Acid Metabolism. npj Biofilms Microbiomes, 9.","DOI":"10.1038\/s41522-023-00399-z"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1021\/acs.jafc.8b02979","article-title":"Pectin Alleviates High Fat (Lard) Diet-Induced Nonalcoholic Fatty Liver Disease in Mice: Possible Role of Short-Chain Fatty Acids and Gut Microbiota Regulated by Pectin","volume":"66","author":"Li","year":"2018","journal-title":"J. Agric. Food Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"116082","DOI":"10.1016\/j.jep.2022.116082","article-title":"Terminalia bellirica Ethanol Extract Ameliorates Nonalcoholic Fatty Liver Disease in Mice by Amending the Intestinal Microbiota and Faecal Metabolites","volume":"305","author":"Zhang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.3748\/wjg.v24.i23.2468","article-title":"Dynamic Alterations in the Gut Microbiota and Metabolome During the Development of Methionine-Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis","volume":"24","author":"Ye","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5114\/aoms.2016.62150","article-title":"Bifidobacteria and Lactobacilli in the Gut Microbiome of Children with Non-Alcoholic Fatty Liver Disease: Which Strains Act as Health Players?","volume":"14","author":"Nobili","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.numecd.2017.10.014","article-title":"Gut Microbiome Composition in Lean Patients with NASH is Associated with Liver Damage Independent of Caloric Intake: A Prospective Pilot Study","volume":"28","author":"Duarte","year":"2018","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pan, X., Kaminga, A.C., Liu, A., Wen, S.W., Luo, M., and Luo, J. (2021). Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children with Nonalcoholic Fatty Liver Disease. Front. Cell. Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.683743"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"812882","DOI":"10.3389\/fphys.2021.812882","article-title":"Human Beta Defensin 2 Ameliorated Alcohol-Associated Liver Disease in Mice","volume":"12","author":"Warner","year":"2022","journal-title":"Front. Physiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lin, Y., Chen, H., Cao, Y., Zhang, Y., Li, W., Guo, W., Lv, X., Rao, P., Ni, L., and Liu, P. (2021). Auricularia auricula Melanin Protects against Alcoholic Liver Injury and Modulates Intestinal Microbiota Composition in Mice Exposed to Alcohol Intake. Foods, 10.","DOI":"10.3390\/foods10102436"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"goac074","DOI":"10.1093\/gastro\/goac074","article-title":"Clinical Outcomes and Gut Microbiota Analysis of Severe Alcohol-Associated Hepatitis Patients Undergoing Healthy Donor Fecal Transplant or Pentoxifylline Therapy: Single-Center Experience from Kerala","volume":"10","author":"Philips","year":"2022","journal-title":"Gastroenterol. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/hep4.1905","article-title":"Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma","volume":"6","author":"Ponziani","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"762930","DOI":"10.3389\/fmed.2021.762930","article-title":"Lactitol Supplementation Modulates Intestinal Microbiome in Liver Cirrhotic Patients","volume":"8","author":"Lu","year":"2021","journal-title":"Front. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.biopha.2018.03.158","article-title":"Effects of Shenling Baizhu Powder Herbal Formula on Intestinal Microbiota in High-Fat Diet-Induced NAFLD Rats","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Yang, F., Feng, B., Niu, Y.J., Hu, C.Y., and Meng, Y.H. (2021). Fu Instant Tea Ameliorates Fatty Liver by Improving Microbiota Dysbiosis and Elevating Short-Chain Fatty Acids in the Intestine of Mice Fed a High-Fat Diet. Food Biosci., 42.","DOI":"10.1016\/j.fbio.2021.101207"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"558525","DOI":"10.3389\/fphar.2020.558525","article-title":"Inulin Exerts Beneficial Effects on Non-Alcoholic Fatty Liver Disease via Modulating gut Microbiome and Suppressing the Lipopolysaccharide-Toll-Like Receptor 4-M\u03c8-Nuclear Factor-\u03baB-Nod-Like Receptor Protein 3 Pathway via Gut-Liver Axis in Mice","volume":"11","author":"Bao","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"112309","DOI":"10.1016\/j.foodres.2022.112309","article-title":"Inulin Intervention Attenuates Hepatic Steatosis in Rats Via Modulating Gut Microbiota and Maintaining Intestinal Barrier Function","volume":"163","author":"Yang","year":"2023","journal-title":"Food Res. Int."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hu, W., Gao, W., Liu, Z., Fang, Z., Wang, H., Zhao, J., Zhang, H., Lu, W., and Chen, W. (2022). Specific Strains of Faecalibacterium prausnitzii Ameliorate Nonalcoholic Fatty Liver Disease in Mice in Association with Gut Microbiota Regulation. Nutrients, 14.","DOI":"10.3390\/nu14142945"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.csbj.2020.12.011","article-title":"Active Phase Prebiotic Feeding Alters Gut Microbiota, Induces Weight-Independent Alleviation of Hepatic Steatosis and Serum Cholesterol in High-Fat Diet-Fed Mice","volume":"19","author":"Ghosh","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jn\/nxaa376","article-title":"Polylactose Exhibits Prebiotic Activity and Reduces Adiposity and Nonalcoholic Fatty Liver Disease in Rats Fed a High-Fat Diet","volume":"151","author":"Abernathy","year":"2021","journal-title":"J. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e625","DOI":"10.1097\/TXD.0000000000001033","article-title":"Characterization of Gut Microbiome in Liver Transplant Recipients with Nonalcoholic Steatohepatitis","volume":"6","author":"Satapathy","year":"2020","journal-title":"Transplant. Direct"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00394-018-1721-2","article-title":"Histological Improvement of Non-Alcoholic Steatohepatitis with a Prebiotic: A Pilot Clinical Trial","volume":"58","author":"Bomhof","year":"2019","journal-title":"Eur. J. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00018-018-2947-0","article-title":"Molecular Pathways of Nonalcoholic Fatty Liver Disease Development and Progression","volume":"76","author":"Bessone","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"17756","DOI":"10.3748\/wjg.v20.i47.17756","article-title":"Pathogenesis of Alcoholic Liver Disease: Role of Oxidative Metabolism","volume":"20","author":"Ceni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Dolicka, D., Sobolewski, C., Correia de Sousa, M., Gjorgjieva, M., and Foti, M. (2020). mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186648"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Wood, B.J.B., and Holzapfel, W.H. (1995). The Genera of Lactic Acid Bacteria, Springer.","DOI":"10.1007\/978-1-4615-5817-0"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"D613","DOI":"10.1093\/nar\/gkt1111","article-title":"LPSN\u2014List of Prokaryotic Names with Standing in Nomenclature","volume":"42","author":"Parte","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijfoodmicro.2010.12.010","article-title":"Genomics and Ecological Overview of the Genus Bifidobacterium","volume":"149","author":"Turroni","year":"2011","journal-title":"Int. J. Food Microbiol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Arboleya, S., Watkins, C., Stanton, C., and Ross, R.P. (2016). Gut Bifidobacteria Populations in Human Health and Aging. Front. Microbiol., 7.","DOI":"10.3389\/fmicb.2016.01204"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e00017-19","DOI":"10.1128\/mSystems.00017-19","article-title":"Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis","volume":"4","author":"Zhang","year":"2019","journal-title":"mSystems"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4014\/jmb.2007.07046","article-title":"Antimicrobial and Immunomodulatory Effects of Bifidobacterium Strains: A Review","volume":"30","author":"Lim","year":"2020","journal-title":"J. Microbiol. Biotechnol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D.B., Morgun, A., and Shulzhenko, N. (2020). Role of Gut Microbiota in Type 2 Diabetes Pathophysiology. eBioMedicine, 51.","DOI":"10.1016\/j.ebiom.2019.11.051"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fpsyt.2019.00034","article-title":"Systematic Review of Gut Microbiota and Major Depression","volume":"10","author":"Cheung","year":"2019","journal-title":"Front. Psychiatry"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apt.15754","article-title":"A Disease-Specific Decline of the Relative Abundance of Bifidobacterium in Patients with Autoimmune Hepatitis","volume":"51","author":"Liwinski","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0168-8278(01)00151-9","article-title":"The Spectrum of Liver Disease in the General Population: Lesson from the Dionysos Study","volume":"35","author":"Bellentani","year":"2001","journal-title":"J. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nutres.2020.09.004","article-title":"Alcohol Use Alters the Colonic Mucosa\u2013Associated Gut Microbiota in Humans","volume":"83","author":"Gurwara","year":"2020","journal-title":"Nutr. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The Role of the Microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","article-title":"Prolonged High-Fat-Diet Feeding Promotes Non-Alcoholic Fatty Liver Disease and Alters Gut Microbiota in Mice","volume":"11","author":"Enos","year":"2019","journal-title":"World J. Hepatol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The Role of the Gut Microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/jn\/nxz154","article-title":"Establishing What Constitutes a Healthy Human Gut Microbiome: State of the Science, Regulatory Considerations, and Future Directions","volume":"149","author":"McBurney","year":"2019","journal-title":"J. Nutr."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","article-title":"Compositional Alterations of Gut Microbiota in Nonalcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Lipids Health Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature18848","article-title":"The Microbiota in Adaptive Immune Homeostasis and Disease","volume":"535","author":"Honda","year":"2016","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Jokela, R., Ponsero, A.J., Dikareva, E., Wei, X., Kolho, K.L., Korpela, K., de Vos, W.M., and Salonen, A. (2023). Sources of Gut Microbiota Variation in a Large Longitudinal Finnish Infant Cohort. EBioMedicine., 94.","DOI":"10.1016\/j.ebiom.2023.104695"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1224092","DOI":"10.3389\/fimmu.2023.1224092","article-title":"Immunomodulatory Effects of Inulin and its Intestinal Metabolites","volume":"14","author":"Sheng","year":"2023","journal-title":"Front Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004836-200203000-00013","article-title":"Update on Nonalcoholic Fatty Liver Disease","volume":"34","author":"McCullough","year":"2002","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cld.1170","article-title":"NASH and the Gut Microbiome: Implications for New Therapies","volume":"19","author":"Tsay","year":"2022","journal-title":"Clin. Liver Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver Cirrhosis","volume":"371","author":"Schuppan","year":"2008","journal-title":"Lancet"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Berzigotti, A. (2017). Advances and Challenges in Cirrhosis and Portal Hypertension. BMC Med., 15.","DOI":"10.1186\/s12916-017-0966-6"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5881","DOI":"10.3748\/wjg.v28.i40.5881","article-title":"Liver Transplantation is Beneficial Regardless of Cirrhosis Stage or Acute-on-Chronic Liver Failure Grade: A Single-Center Experience","volume":"28","author":"Vilatoba","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/cld.827","article-title":"Altered Microbiota in Cirrhosis and its Relationship to the Development of Infection","volume":"14","author":"Bajaj","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cld.2022.08.004","article-title":"Hepatocellular Carcinoma: New Developments","volume":"27","author":"Ganesan","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"879","DOI":"10.12688\/f1000research.6946.1","article-title":"Molecular Pathogenesis of Hepatocellular Carcinoma and Impact of Therapeutic Advances","volume":"5","author":"Dhanasekaran","year":"2016","journal-title":"F1000Research"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Luo, W., Guo, S., Zhou, Y., Zhao, J., Wang, M., Sang, L., Chang, B., and Wang, B. (2022). Hepatocellular Carcinoma: How the Gut Microbiota Contributes to Pathogenesis, Diagnosis, and Therapy. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.873160"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Litwinowicz, K., and Gamian, A. (2023). Microbiome Alterations in Alcohol Use Disorder and Alcoholic Liver Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032461"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41467-020-17041-7","article-title":"Analysis of Compositions of Microbiomes with Bias Correction","volume":"11","author":"Lin","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41591-021-01552-x","article-title":"Reporting Guidelines for Human Microbiome Research: The STORMS Checklist","volume":"27","author":"Mirzayi","year":"2021","journal-title":"Nat. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/12\/2999\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:40:21Z","timestamp":1760132421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/11\/12\/2999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,17]]},"references-count":79,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["microorganisms11122999"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms11122999","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,17]]}}}